267
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Research

Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?

, , , , , , , & show all
Pages 2218-2226 | Received 27 Aug 2016, Accepted 18 Jan 2017, Published online: 03 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Harivenkatesh Natarajan, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Thirumurthy Velpandian, Madhulika Kabra, Ajay Gogia, Nihar Ranjan Biswas & Yogendra Kumar Gupta. (2019) Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Leukemia & Lymphoma 60:2, pages 418-425.
Read now

Articles from other publishers (1)

Viktor Hlaváč, Petr Holý & Pavel Souček. (2020) Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450. Journal of Personalized Medicine 10:3, pages 108.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.